India, Oct. 21 -- Allergan Aesthetics, an AbbVie company (ABBV), announced that it will present eight scientific posters featuring new and long-term clinical evidence across its aesthetics portfolio at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) Dubai, taking place October 21-23, 2026.
The presentations highlight clinical findings for HArmonyCa, JUVEDERM, SKINVIVE and BOTOX Cosmetic, supporting the company's personalized approach to aesthetic treatment.
HArmonyCa is a hybrid injectable that combines hyaluronic acid (HA), which provides an immediate lifting effect, with calcium hydroxyapatite (CaHA), which supports longer-term biostimulation. The treatment is designed to address facial volume and skin quality through compleme...